이상반응 보고

VAERS ID	1864269
성별	알 수 없음
나이
주 코드	SD
제약회사	MODERNA
로트 번호	23C21A
예방접종 횟수	3
접종일
발병일
상태	회복

증상

• 유통기한이 지난 제품이 관리됨(Expired product administered)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

patients received a refrozen dose of vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients received a refrozen dose of vaccine) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no.
23C21A) for COVID-19 vaccination.
No Medical History information was reported.
On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .
25 milliliter.
On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients received a refrozen dose of vaccine).
At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients received a refrozen dose of vaccine) had resolved.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No concomitant and treatment medications were provided.
; Sender's Comments: This is a case of Expired Product Administered concerning an elderly patient of unknown gender with no relevant medical history, who experienced no other associated adverse events.
The events occurred on an unknown date after receiving the third dose number of mRNA-1273 (Moderna COVID-19 Vaccine).
The rechallenge is unknown since no information on other doses were disclosed.
The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.